Last Posted: Sep 27, 2019
- A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
Georgescu Constantin et al. BMC cancer 2019 May 19(1) 423 - Development of a five-gene signature as a novel prognostic marker in ovarian cancer.
Wang R et al. Neoplasma 2019 May 66(3) 343-349 - Early Transcriptional Responses After Dengue Vaccination Mirror the Response to Natural Infection and Predict Neutralizing Antibody Titers.
Popper Stephen J et al. The Journal of infectious diseases 2018 218(12) 1911-1921 - IDENTIFICATION OF EXPRESSION PROFILES DEFINING DISTINCT PROGNOSTIC SUBSETS OF RADIOACTIVE-IODINE REFRACTORY DIFFERENTIATED THYROID CANCER FROM THE DECISION TRIAL.
Capdevila Jaume et al. Molecular cancer therapeutics 2019 Sep - Interfocal heterogeneity challenges the clinical usefulness of molecular classification of primary prostate cancer.
Carm Kristina Totland et al. Scientific reports 2019 Sep 9(1) 13579 - Performance of the Afirma genomic sequencing classifier versus gene expression classifier: An institutional experience.
Wei Shuanzeng et al. Cancer cytopathology 2019 Sep - The four‑microRNA signature identified by bioinformatics analysis predicts the prognosis of nasopharyngeal carcinoma patients.
Zhang Siwei et al. Oncology reports 2019 Sep - Translational Genomics and Recent Advances in Oral Squamous Cell Carcinoma.
Yeeng Chai Annie Wai et al. Seminars in cancer biology 2019 Sep - Is Everyone Doing Chemo Without Me?
J Wana, NY Times, September 24, 2019 - A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Yin et al. BMC cancer 2019 Sep 19(1) 886
No hay comentarios:
Publicar un comentario